Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
Clinical trial NCT07226765 · RECRUITING
Trial details
- NCT number
- NCT07226765
- Sponsor
- Amgen
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-25
- Primary completion
- 2027-09-29
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.